Encompass Health Co. (NYSE:EHC) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of Encompass Health Co. (NYSE:EHC) have been given a consensus recommendation of “Buy” by the eleven ratings firms that are currently covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $107.11.

A number of analysts have recently weighed in on EHC shares. Royal Bank of Canada raised their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays boosted their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp lifted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th.

Encompass Health Trading Up 0.6 %

NYSE:EHC opened at $98.99 on Friday. The firm has a 50 day moving average of $96.52 and a 200 day moving average of $94.70. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a 52 week low of $70.83 and a 52 week high of $104.55. The stock has a market capitalization of $9.97 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 1.14 and a beta of 0.89.

Hedge Funds Weigh In On Encompass Health

Institutional investors have recently modified their holdings of the stock. MassMutual Private Wealth & Trust FSB grew its holdings in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the period. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at $40,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.